by Proactive LTC Consulting | Aug 16, 2021 | 5-Star, Blog, Nursing, Regulatory, Survey
F761 Label/Store Drugs and Biologicals is currently the 8th most frequently cited deficiency throughout the nation thus far in FY2021. Source: CASPER 08/08/2021 REGULATION The F761 regulation includes three requirements: Labeling – (1) Drugs and biologicals...
by Proactive LTC Consulting | May 28, 2025 | Clinical, Compliance, F-Tag, Pharmacy, Regulatory, Survey
Q: What are the most common reasons for the citing of F761 – Storage of Drugs and Biologicals? A: In Appendix PP the regulatory guidance for F761 is as follows: §483.45(g) Labeling of Drugs and Biologicals Drugs and biologicals used in the facility must be...
by Proactive LTC Consulting | Oct 25, 2022 | Blog, F-Tag
The prevalence of psychotropic drugs in nursing homes has increased in recent years in part due to the worsening of emotional and behavioral disorders exacerbated by the restrictive measures of the COVID-19 pandemic.[1] Consequently, F758 Psychotropic Drugs is one of...
by Proactive LTC Consulting | Mar 31, 2021 | Antipsychotics/Psychotropics, Blog, Compliance, Nursing, Quality Measure, Regulatory, SNF
Are you ready for the annual survey and the Unnecessary Medications, Psychotropic Medications, and Medication Regimen Review task that is part of that process? Surveyors select 5 residents to conduct this review on following the Critical Element Pathway. Consider...
by Proactive LTC Consulting | Mar 9, 2022 | Blog
F 761 Label/Store Drugs & Biologicals is consistently a “Top 10” deficiency. Compliance with F761 is complicated by the vast number of medications and related supplies that facilities must utilize each day, along with the multiple places they must be stored,...
